2023 article

Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease Research outline and call for collaboration

Lathe, R., Schultek, N. M., Balin, B. J., Ehrlich, G. D., Auber, L. A., Perry, G., … Tanzi, R. E. (2023, June 7). ALZHEIMERS & DEMENTIA.

By: R. Lathe*, N. Schultek, B. Balin*, G. Ehrlich*, L. Auber, G. Perry*, E. Breitschwerdt n, D. Corry* ...

author keywords: Alzheimer's disease; antimicrobial; antiviral; bioinformatics; blood; cerebrospinal fluid; collaboration; dementia; diagnosis; methodology; microbiome; mild cognitive impairment; olfactory neuroepithelium; pathobiome; polymerase chain reaction; protocol; sequencing
TL;DR: The Alzheimer's Pathobiome Initiative aims to perform comparative molecular analyses of microbes in post mortem brains versus cerebrospinal fluid, blood, olfactory neuroepithelium, oral/nasopharyngeal tissue, bronchoalveolar, urinary, and gut/stool samples to provide a roadmap for detecting infectious agents in patients with mild cognitive impairment or AD. (via Semantic Scholar)
Source: Web Of Science
Added: July 3, 2023

Abstract